COLESTIPOL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Colestipol Hydrochloride patents expire, and when can generic versions of Colestipol Hydrochloride launch?
Colestipol Hydrochloride is a drug marketed by Impax Labs, Ani Pharms, Edenbridge Pharms, and Zydus Pharms. and is included in five NDAs.
The generic ingredient in COLESTIPOL HYDROCHLORIDE is colestipol hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Colestipol Hydrochloride
A generic version of COLESTIPOL HYDROCHLORIDE was approved as colestipol hydrochloride by IMPAX LABS on May 2nd, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COLESTIPOL HYDROCHLORIDE?
- What are the global sales for COLESTIPOL HYDROCHLORIDE?
- What is Average Wholesale Price for COLESTIPOL HYDROCHLORIDE?
Summary for COLESTIPOL HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 20 |
Clinical Trials: | 11 |
Patent Applications: | 332 |
What excipients (inactive ingredients) are in COLESTIPOL HYDROCHLORIDE? | COLESTIPOL HYDROCHLORIDE excipients list |
DailyMed Link: | COLESTIPOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for COLESTIPOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ain Shams University | Phase 4 |
Instituto Nacional de Salud Publica, Mexico | Phase 3 |
Laboratorios Grossman, S.A. | Phase 3 |
Pharmacology for COLESTIPOL HYDROCHLORIDE
Drug Class | Bile Acid Sequestrant |
Mechanism of Action | Bile-acid Binding Activity |